← Leaderboards

Rakesh K. Jain

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗

$48,476,214

Attributed

$53,740,800

Total exposure

21

Grants

15

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.9M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$88,758,452 · 22

By mechanism

P01$38,737,120 · 6

R01$26,915,251 · 8

R24$8,338,056 · 1

U01$5,978,304 · 2

R35$5,729,712 · 1

T32$2,993,509 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Bakhos A. Tannous$11,831,527
Robert L Martuza$21,256,149
Samuel D Rabkin$6,893,969
Lance L Munn$15,934,149
Xandra Owens Breakefield$30,735,276

Others in their field

Top investigators on “Tumor”

David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
Richard K. Wilson · Washington University$203,917,615
Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819

Research focus

TumorCellsMalignant NeoplasmsInsightPathway InteractionsClinical TrialsCancer CellDesignMolecularBaseIn VivoFutureProgramsSignal TransductionSolid NeoplasmAntibodiesBlood VesselsResponseGrowthTissuesMediatingPharmaceutical PreparationsImplantTumor Growth

Grant awards (109)

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$623,782

U01 · FY2025 · CA

Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism$468,333

R01 · FY2025 · CA · contact PI

Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma$379,634

R01 · FY2025 · CA · contact PI

Critical Issues in the Tumor Microenvironment$50,000

R13 · FY2025 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$592,593

U01 · FY2024 · CA

Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism$444,607

R01 · FY2024 · CA · contact PI

Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma$360,653

R01 · FY2024 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$611,307

U01 · FY2023 · CA

Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism$458,340

R01 · FY2023 · CA · contact PI

Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma$372,041

R01 · FY2023 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$611,308

U01 · FY2022 · CA

Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism$458,041

R01 · FY2022 · CA · contact PI

Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma$379,634

R01 · FY2022 · CA · contact PI

Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance$623,782

U01 · FY2021 · CA

Reprogramming PDAC tumor microenvironment to improve immunotherapy$577,095

U01 · FY2021 · CA · contact PI

Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism$483,164

R01 · FY2021 · CA · contact PI

Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment$1,044,000

R35 · FY2020 · CA · contact PI

Reprogramming PDAC tumor microenvironment to improve immunotherapy$577,095

U01 · FY2020 · CA · contact PI

Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment$477,379

R01 · FY2020 · CA

Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment$1,012,680

R35 · FY2019 · CA · contact PI

Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment$463,057

R01 · FY2019 · CA

Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment$1,044,000

R35 · FY2018 · CA · contact PI

Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment$477,379

R01 · FY2018 · CA

Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment$162,720

R01 · FY2018 · CA

Reprogramming PDAC tumor microenvironment to improve immunotherapy$1,761,342

U01 · FY2017 · CA · contact PI

Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment$1,044,000

R35 · FY2017 · CA · contact PI

Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment$495,129

R01 · FY2017 · CA

Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment$162,720

R01 · FY2017 · CA

Integrative Pathophysiology of Solid Tumors$2,237,643

P01 · FY2016 · CA · contact PI

Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment$1,044,000

R35 · FY2016 · CA · contact PI

Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma$253,386

P01 · FY2016 · CA · contact PI

Administrative Core$195,753

P01 · FY2016 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,264,020

P01 · FY2015 · CA · contact PI

Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment$541,032

R35 · FY2015 · CA · contact PI

Improving treatment of brain metastases from HER2-positive breast cancer$398,025

R01 · FY2015 · CA · contact PI

Role of PLGF in Medulloblastoma Progression and Treatment$338,816

R01 · FY2015 · CA · contact PI

Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma$253,387

P01 · FY2015 · CA · contact PI

Administrative Core$195,753

P01 · FY2015 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,196,096

P01 · FY2014 · CA · contact PI

Role of PLGF in Medulloblastoma Progression and Treatment$328,652

R01 · FY2014 · CA · contact PI

Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma$244,897

P01 · FY2014 · CA · contact PI

Administrative Core$187,264

P01 · FY2014 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,155,490

P01 · FY2013 · CA · contact PI

Role of PLGF in Medulloblastoma Progression and Treatment$318,487

R01 · FY2013 · CA · contact PI

Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma$238,194

P01 · FY2013 · CA · contact PI

Administrative Core$184,002

P01 · FY2013 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,243,002

P01 · FY2012 · CA · contact PI

Probing Tumor Microenvironment Using Nanotechnology$1,507,967

R01 · FY2012 · CA · contact PI

Role of PLGF in Medulloblastoma Progression and Treatment$344,860

R01 · FY2012 · CA · contact PI

Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma$253,993

P01 · FY2012 · CA · contact PI

Administrative Core$196,222

P01 · FY2012 · CA · contact PI

Training Program in Integrative Pathophysiology of Solid Tumors$137,714

T32 · FY2012 · CA · contact PI

Probing Tumor Microenvironment Using Nanotechnology$1,541,419

R01 · FY2011 · CA · contact PI

Training Program in Integrative Pathophysiology of Solid Tumors$262,679

T32 · FY2011 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,267,078

P01 · FY2010 · CA · contact PI

Probing Tumor Microenvironment Using Nanotechnology$1,645,245

R01 · FY2010 · CA · contact PI

Role of BMDCs in Solid Tumor Growth and Relapse$453,187

R01 · FY2010 · CA · contact PI

Improving Interstitial Transport in Tumors$310,646

P01 · FY2010 · CA · contact PI

Training Program in Integrative Pathophysiology of Solid Tumors$234,691

T32 · FY2010 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,251,085

P01 · FY2009 · CA · contact PI

Integrative Biology of Tumor Metastasis$1,692,056

R01 · FY2009 · CA · contact PI

Probing Tumor Microenvironment Using Nanotechnology$1,653,293

R01 · FY2009 · CA · contact PI

Role of BMDCs in Solid Tumor Growth and Relapse$453,295

R01 · FY2009 · CA · contact PI

Improving Interstitial Transport in Tumors$304,190

P01 · FY2009 · CA · contact PI

Training Program in Integrative Pathophysiology of Solid Tumors$265,030

T32 · FY2009 · CA · contact PI

Probing Tumor Microenvironment Using Nanotechnology$250,000

R01 · FY2009 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,216,012

P01 · FY2008 · CA · contact PI

Integrative Biology of Tumor Metastasis$1,748,429

R01 · FY2008 · CA · contact PI

Probing Tumor Microenvironment Using Nanotechnology$1,692,884

R01 · FY2008 · CA · contact PI

Role of BMDCs in Solid Tumor Growth and Relapse$439,670

R01 · FY2008 · CA · contact PI

Improving Interstitial Transport in Tumors$318,317

P01 · FY2008 · CA · contact PI

Training Program in Integrative Pathophysiology of Solid Tumors$270,435

T32 · FY2008 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,226,580

P01 · FY2007 · CA · contact PI

Integrative Biology of Tumor Metastasis$1,739,044

R01 · FY2007 · CA · contact PI

Role of BMDCs in Solid Tumor Growth and Relapse$431,698

R01 · FY2007 · CA · contact PI

Improving Interstitial Transport in Tumors$309,412

P01 · FY2007 · CA · contact PI

Training Program in Pathophysiology of Solid Tumors$262,418

T32 · FY2007 · CA · contact PI

Integrative Pathophysiology of Solid Tumors$2,226,000

P01 · FY2006 · CA · contact PI

Integrative Biology of Tumor Metastasis$1,743,224

R01 · FY2006 · CA · contact PI

Role of BMDCs in Solid Tumor Growth and Relapse$435,049

R01 · FY2006 · CA · contact PI

Training Program in Pathophysiology of Solid Tumors$262,772

T32 · FY2006 · CA · contact PI

Improving Interstitial Transport in Tumors$159,747

P01 · FY2006 · CA · contact PI

Administrative Core$114,305

P01 · FY2006 · CA · contact PI

Integrative Biology of Tumor Metastasis$1,717,120

R01 · FY2005 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$794,929

P01 · FY2005 · CA

Training Program in Pathophysiology of Solid Tumors$250,015

T32 · FY2005 · CA

Anti-Angiogenesis/Drugs in Tumors--Bench /Bedside &Back$9,000

R13 · FY2005 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$2,378,051

P01 · FY2004 · CA

BIOLOGY OF TUMOR ANGIOGENESIS, INVASION AND METASTASIS$1,730,578

R24 · FY2004 · CA

Training Program in Pathophysiology of Solid Tumors$265,261

T32 · FY2004 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$2,326,802

P01 · FY2003 · CA

BIOLOGY OF TUMOR ANGIOGENESIS, INVASION AND METASTASIS$1,693,357

R24 · FY2003 · CA

Supplement to PO1 CA-80124-03-Integrative Pathophysiol$418,679

P01 · FY2003 · CA

Training Program in Pathophysiology of Solid Tumors$225,925

T32 · FY2003 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$2,273,048

P01 · FY2002 · CA

BIOLOGY OF TUMOR ANGIOGENESIS, INVASION AND METASTASIS$1,649,101

R24 · FY2002 · CA

TRAINING IN INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$199,147

T32 · FY2002 · CA

Conference on Angiogenesis in Cancer and Other Diseases$7,500

R13 · FY2002 · CA

Transport properties of tumor interstitium$0

P01 · FY2002 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$2,260,157

P01 · FY2001 · CA

BIOLOGY OF TUMOR ANGIOGENESIS, INVASION AND METASTASIS$1,638,056

R24 · FY2001 · CA

TRAINING IN INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$164,528

T32 · FY2001 · CA

Transport properties of tumor interstitium$0

P01 · FY2001 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$2,211,793

P01 · FY2000 · CA

BIOLOGY OF TUMOR ANGIOGENESIS, INVASION AND METASTASIS$1,626,964

R24 · FY2000 · CA

TRAINING IN INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$192,894

T32 · FY2000 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS$71,187

P01 · FY2000 · CA

Transport properties of tumor interstitium$0

P01 · FY2000 · CA

Transport properties of tumor interstitium$0

P01 · FY2000 · CA